163 related articles for article (PubMed ID: 8387782)
1. Identification of a receptor for ADP on blood platelets by photoaffinity labelling.
Cristalli G; Mills DC
Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):875-81. PubMed ID: 8387782
[TBL] [Abstract][Full Text] [Related]
2. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets.
Macfarlane DE; Srivastava PC; Mills DC
J Clin Invest; 1983 Mar; 71(3):420-8. PubMed ID: 6298277
[TBL] [Abstract][Full Text] [Related]
3. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
Puri RN; Colman RF; Colman RW
Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
[TBL] [Abstract][Full Text] [Related]
4. Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.
Hall DA; Hourani SM
Br J Pharmacol; 1993 Mar; 108(3):728-33. PubMed ID: 8467360
[TBL] [Abstract][Full Text] [Related]
5. A novel method for chemical modification of functional groups other than a carboxyl group in proteins by N-ethyl-5-phenylisooxazolium-3'-sulfonate (Woodward's reagent-K): inhibition of ADP-induced platelet responses involves covalent modification of aggregin, an ADP receptor.
Puri RN; Colman RW
Anal Biochem; 1996 Sep; 240(2):251-61. PubMed ID: 8811919
[TBL] [Abstract][Full Text] [Related]
6. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.
Mills DC; Puri R; Hu CJ; Minniti C; Grana G; Freedman MD; Colman RF; Colman RW
Arterioscler Thromb; 1992 Apr; 12(4):430-6. PubMed ID: 1558834
[TBL] [Abstract][Full Text] [Related]
7. Competitive inhibition by adenosine 5'-triphosphate of the actions on human platelets of 2-chloroadenosine 5'-diphosphate, 2-azidoadenosine 5'-diphosphate and 2-methylthioadenosine 5'-diphosphate.
Cusack NJ; Hourani SM
Br J Pharmacol; 1982 Oct; 77(2):329-33. PubMed ID: 7139191
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of ADP-induced platelet responses by covalent modification of aggregin, a putative ADP receptor, by 8-(4-bromo-2,3-dioxobutylthio)ADP.
Puri RN; Kumar A; Chen H; Colman RF; Colman RW
J Biol Chem; 1995 Oct; 270(41):24482-8. PubMed ID: 7592664
[TBL] [Abstract][Full Text] [Related]
9. The human platelet ADP receptor activates Gi2 proteins.
Ohlmann P; Laugwitz KL; Nürnberg B; Spicher K; Schultz G; Cazenave JP; Gachet C
Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):775-9. PubMed ID: 8554519
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ADP-induced platelet shape change and aggregation by o-phthalaldehyde: evidence for covalent modification of cysteine and lysine residues.
Puri RN; Colman RW
Arch Biochem Biophys; 1991 May; 286(2):419-27. PubMed ID: 1910292
[TBL] [Abstract][Full Text] [Related]
11. [32P]3'-O-(4-benzoyl)benzoyl ATP as a photoaffinity label for a phospholipase C-coupled P2Y-purinergic receptor.
Boyer JL; Cooper CL; Harden TK
J Biol Chem; 1990 Aug; 265(23):13515-20. PubMed ID: 2199438
[TBL] [Abstract][Full Text] [Related]
12. Photoaffinity labeling of mitochondrial adenosinetriphosphatase by 2-azidoadenosine 5'-[alpha-32P]diphosphate.
Boulay F; Dalbon P; Vignais PV
Biochemistry; 1985 Dec; 24(25):7372-9. PubMed ID: 2867780
[TBL] [Abstract][Full Text] [Related]
13. Identification of high-affinity (Kd 0.35 mumol/L) and low-affinity (Kd 7.9 mumol/L) platelet binding sites for ADP and competition by ADP analogues.
Jefferson JR; Harmon JT; Jamieson GA
Blood; 1988 Jan; 71(1):110-6. PubMed ID: 3334892
[TBL] [Abstract][Full Text] [Related]
14. Solubilization of a guanine nucleotide-sensitive form of the P2Y-purinergic receptor.
Jeffs RA; Cooper CL; Harden TK
Mol Pharmacol; 1991 Jul; 40(1):85-92. PubMed ID: 1906978
[TBL] [Abstract][Full Text] [Related]
15. Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclase.
Mills DC; Figures WR; Scearce LM; Stewart GJ; Colman RF; Colman RW
J Biol Chem; 1985 Jul; 260(13):8078-83. PubMed ID: 2989276
[TBL] [Abstract][Full Text] [Related]
16. Binding of 2-azidoadenosine [beta-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase.
Macfarlane DE; Mills DC; Srivastava PC
Biochemistry; 1982 Feb; 21(3):544-9. PubMed ID: 6279146
[No Abstract] [Full Text] [Related]
17. Two distinct regions of the yeast mitochondrial ADP/ATP carrier are photolabeled by a new ADP analogue: 2-azido-3'-O-naphthoyl-[beta-32P]ADP. Identification of the binding segments by mass spectrometry.
Dianoux AC; Noël F; Fiore C; Trézéguet V; Kieffer S; Jaquinod M; Lauquin GJ; Brandolin G
Biochemistry; 2000 Sep; 39(37):11477-87. PubMed ID: 10985794
[TBL] [Abstract][Full Text] [Related]
18. ADP-induced platelet shape change and mobilization of cytoplasmic ionized calcium are mediated by distinct binding sites on platelets: 5'-p-fluorosulfonylbenzoyladenosine is a weak platelet agonist.
Rao AK; Kowalska MA
Blood; 1987 Sep; 70(3):751-6. PubMed ID: 3040154
[TBL] [Abstract][Full Text] [Related]
19. Covalent modification of the catalytic sites of the H+-ATPase from chloroplasts and 2-nitreno-ADP. Modification of the catalytic site 1 (tight) and catalytic sites 1 and 2 together impairs both uni-site and multi-site catalysis of ATP synthesis and ATP hydrolysis.
Possmayer FE; Hartog AF; Berden JA; Gräber P
Biochim Biophys Acta; 2000 Jul; 1459(1):202-17. PubMed ID: 10924912
[TBL] [Abstract][Full Text] [Related]
20. Photoaffinity labeling of integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) on intact platelets with 8-azido-[gamma-32P]ATP.
Mayinger P; Gawaz M
Biochim Biophys Acta; 1992 Oct; 1137(1):77-81. PubMed ID: 1390904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
